Israel Active

Israel’s Iguazio (reported previously) is to provide Israel’s Sheba Medical Center with clinical, real-time predictive insights from its AI Data Science Platform to help optimize care for Covid-19 patients. Iguazio’s systems will also help Sheba reduce delays in transporting patients.

Israel’s Yehonatan Medical together with Sheba Medical Center have devised a ventilation system with a high-power output and built-in disinfecting mechanism that can treat between three and five patients simultaneously. It includes AI technology for alerting and adjusting to patient responsiveness.

Israel’s Exero Medical (reported previously) has received Breakthrough device designation by the US FDA for its implantable biodegradable wireless sensor designed to continuously monitor for gastrointestinal leaks and healing status after surgery.

Jerusalem’s Hadassah-University Medical Center and Israel’s NeuroGenesis have developed a stem cell treatment for patients with progressive multiple sclerosis. A Phase II human trial not only halted progression of the disease but led to improvement in neurological ability.

An end to the coronavirus pandemic is in sight as hundreds of thousands of doses of Pfizer vaccines were flown into Tel Aviv. Vaccinations are due to begin on Dec 27. Israel is scheduled to receive 4 million doses of the vaccine by end Dec.

Progress has been made with the Israeli-developed vaccines and treatments. The MigVax oral vaccine is ideal for developing countries as it easy to transport and distribute. It is also much safer, e.g., for those who have allergies or compromised immune systems.

Israeli-Arab orthopaedists, neurologists, heart surgeons, and mental health experts are in the Gaza Strip relieving the strain on hospitals fighting coronavirus. They are conducting urgent (previously postponed) surgeries on non-Covid-19 patients and training up Palestinian Arab medical teams.

Israel’s Maccabi Healthcare Services research and innovation center has initiated KSM Playzone – focusing on the field of health gaming. KSM has awarded $25,000 to the developers of two health education games – Diabattle (for diabetics) and Memento (cognitive rehabilitation).

The OLO finger-prick blood tests from Israel’s Sight Diagnostics (reported previously) will soon be available in medical centers across the Gulf region. The Israeli company is partnering with Dubai’s Phoenix Capital who will install OLO initially in the UAE and then other Gulf states.

Israeli innovators and entrepreneurs participated in Hackautism 2.0 - a virtual tech marathon to create innovative technological solutions for the challenges of children and adults on the Autism Spectrum. The winning teams addressed sleep quality, non-verbal communication and job finding,